German ruling paves way for access to ReWalk
MARLBOROUGH, Mass. – The ReWalk exoskeleton system has been declared medically necessary by the Social Welfare Court of Speyer in Germany, announced ReWalk Robotics, the developer and manufacturer of the ReWalk. The ruling, delivered in July, states that the system should be covered by insurance for an individual with spinal cord injury, overturning the original denial of the claim by the payer, a statutory health insurance entity. "This ruling is a milestone for insurance coverage of exoskeleton technology, both in Germany and around the world," said Larry Jasinski, CEO, in a release. "With each decision approving coverage of the ReWalk, we make key advances in the effort to ensure every eligible ReWalk user has access to and coverage of their system." ReWalk is a robotic exoskeleton that provides powered hip and knee motion to enable individuals with spinal cord injury to stand upright and walk, and is the first exoskeleton system to receive Food & Drug Administration clearance for use in the home and the rehabilitation setting. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany.